nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.079	0.234	CbGbCtD
Cabazitaxel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0558	0.165	CbGbCtD
Cabazitaxel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0377	0.111	CbGbCtD
Cabazitaxel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0359	0.106	CbGbCtD
Cabazitaxel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.032	0.0948	CbGbCtD
Cabazitaxel—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0314	0.0928	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0296	0.0877	CbGbCtD
Cabazitaxel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0188	0.0556	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0177	0.0525	CbGbCtD
Cabazitaxel—TUBB3—respiratory system—chronic obstructive pulmonary disease	0.00662	0.0504	CbGeAlD
Cabazitaxel—TUBB3—connective tissue—chronic obstructive pulmonary disease	0.00583	0.0444	CbGeAlD
Cabazitaxel—Docetaxel—EGFR—chronic obstructive pulmonary disease	0.00579	1	CrCbGaD
Cabazitaxel—TUBA4A—respiratory system—chronic obstructive pulmonary disease	0.00503	0.0383	CbGeAlD
Cabazitaxel—TUBA4A—connective tissue—chronic obstructive pulmonary disease	0.00443	0.0337	CbGeAlD
Cabazitaxel—TUBA4A—bronchus—chronic obstructive pulmonary disease	0.00414	0.0315	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00405	0.0308	CbGeAlD
Cabazitaxel—TUBB4A—respiratory system—chronic obstructive pulmonary disease	0.00403	0.0307	CbGeAlD
Cabazitaxel—TUBB2B—respiratory system—chronic obstructive pulmonary disease	0.0039	0.0297	CbGeAlD
Cabazitaxel—TUBA4A—trachea—chronic obstructive pulmonary disease	0.00372	0.0283	CbGeAlD
Cabazitaxel—TUBB2A—respiratory system—chronic obstructive pulmonary disease	0.00367	0.0279	CbGeAlD
Cabazitaxel—TUBB6—respiratory system—chronic obstructive pulmonary disease	0.00362	0.0275	CbGeAlD
Cabazitaxel—TUBB4A—connective tissue—chronic obstructive pulmonary disease	0.00355	0.027	CbGeAlD
Cabazitaxel—TUBB3—lung—chronic obstructive pulmonary disease	0.00352	0.0268	CbGeAlD
Cabazitaxel—TUBB2B—connective tissue—chronic obstructive pulmonary disease	0.00343	0.0261	CbGeAlD
Cabazitaxel—TUBB2A—connective tissue—chronic obstructive pulmonary disease	0.00323	0.0246	CbGeAlD
Cabazitaxel—TUBB2B—bronchus—chronic obstructive pulmonary disease	0.00321	0.0244	CbGeAlD
Cabazitaxel—TUBB4B—respiratory system—chronic obstructive pulmonary disease	0.00314	0.0239	CbGeAlD
Cabazitaxel—SLCO1B3—lung—chronic obstructive pulmonary disease	0.00308	0.0235	CbGeAlD
Cabazitaxel—TUBB—bronchus—chronic obstructive pulmonary disease	0.00303	0.0231	CbGeAlD
Cabazitaxel—TUBB2A—bronchus—chronic obstructive pulmonary disease	0.00302	0.023	CbGeAlD
Cabazitaxel—TUBB6—bronchus—chronic obstructive pulmonary disease	0.00298	0.0227	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00297	0.0226	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00295	0.0225	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—chronic obstructive pulmonary disease	0.00291	0.0222	CbGeAlD
Cabazitaxel—TUBB2B—trachea—chronic obstructive pulmonary disease	0.00288	0.0219	CbGeAlD
Cabazitaxel—TUBB4B—connective tissue—chronic obstructive pulmonary disease	0.00277	0.0211	CbGeAlD
Cabazitaxel—TUBB—trachea—chronic obstructive pulmonary disease	0.00272	0.0207	CbGeAlD
Cabazitaxel—TUBB2A—trachea—chronic obstructive pulmonary disease	0.00271	0.0206	CbGeAlD
Cabazitaxel—TUBB6—trachea—chronic obstructive pulmonary disease	0.00267	0.0204	CbGeAlD
Cabazitaxel—TUBA4A—lung—chronic obstructive pulmonary disease	0.00267	0.0203	CbGeAlD
Cabazitaxel—TUBB4B—bronchus—chronic obstructive pulmonary disease	0.00259	0.0197	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00253	0.0193	CbGeAlD
Cabazitaxel—TUBB4B—trachea—chronic obstructive pulmonary disease	0.00232	0.0177	CbGeAlD
Cabazitaxel—TUBB4A—lung—chronic obstructive pulmonary disease	0.00214	0.0163	CbGeAlD
Cabazitaxel—TUBB2B—lung—chronic obstructive pulmonary disease	0.00207	0.0158	CbGeAlD
Cabazitaxel—TUBB—lung—chronic obstructive pulmonary disease	0.00196	0.0149	CbGeAlD
Cabazitaxel—TUBB2A—lung—chronic obstructive pulmonary disease	0.00195	0.0148	CbGeAlD
Cabazitaxel—TUBB6—lung—chronic obstructive pulmonary disease	0.00192	0.0146	CbGeAlD
Cabazitaxel—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00172	0.0131	CbGeAlD
Cabazitaxel—TUBB4B—lung—chronic obstructive pulmonary disease	0.00167	0.0127	CbGeAlD
Cabazitaxel—ABCG2—lung—chronic obstructive pulmonary disease	0.000984	0.0075	CbGeAlD
Cabazitaxel—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000914	0.00696	CbGeAlD
Cabazitaxel—CYP3A5—lung—chronic obstructive pulmonary disease	0.000914	0.00696	CbGeAlD
Cabazitaxel—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000794	0.00209	CcSEcCtD
Cabazitaxel—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000794	0.00209	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000792	0.00208	CcSEcCtD
Cabazitaxel—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000789	0.00208	CcSEcCtD
Cabazitaxel—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00207	CcSEcCtD
Cabazitaxel—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00206	CcSEcCtD
Cabazitaxel—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00206	CcSEcCtD
Cabazitaxel—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000779	0.00205	CcSEcCtD
Cabazitaxel—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000779	0.00205	CcSEcCtD
Cabazitaxel—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000774	0.00204	CcSEcCtD
Cabazitaxel—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00077	0.00203	CcSEcCtD
Cabazitaxel—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000765	0.00201	CcSEcCtD
Cabazitaxel—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000765	0.00201	CcSEcCtD
Cabazitaxel—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000763	0.00201	CcSEcCtD
Cabazitaxel—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000756	0.00199	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00198	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00198	CcSEcCtD
Cabazitaxel—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00075	0.00197	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.00196	CcSEcCtD
Cabazitaxel—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00195	CcSEcCtD
Cabazitaxel—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000736	0.00194	CcSEcCtD
Cabazitaxel—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000736	0.00194	CcSEcCtD
Cabazitaxel—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000731	0.00192	CcSEcCtD
Cabazitaxel—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000731	0.00192	CcSEcCtD
Cabazitaxel—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000722	0.0019	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000711	0.00187	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00187	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000708	0.00186	CcSEcCtD
Cabazitaxel—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000707	0.00186	CcSEcCtD
Cabazitaxel—Cough—Formoterol—chronic obstructive pulmonary disease	0.000707	0.00186	CcSEcCtD
Cabazitaxel—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000701	0.00184	CcSEcCtD
Cabazitaxel—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00184	CcSEcCtD
Cabazitaxel—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00184	CcSEcCtD
Cabazitaxel—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000693	0.00182	CcSEcCtD
Cabazitaxel—Cough—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00182	CcSEcCtD
Cabazitaxel—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00182	CcSEcCtD
Cabazitaxel—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00181	CcSEcCtD
Cabazitaxel—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00181	CcSEcCtD
Cabazitaxel—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000688	0.00181	CcSEcCtD
Cabazitaxel—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000687	0.00181	CcSEcCtD
Cabazitaxel—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000687	0.00181	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.0018	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000685	0.0018	CcSEcCtD
Cabazitaxel—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000682	0.00179	CcSEcCtD
Cabazitaxel—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000682	0.00179	CcSEcCtD
Cabazitaxel—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00178	CcSEcCtD
Cabazitaxel—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00178	CcSEcCtD
Cabazitaxel—ABCB1—trachea—chronic obstructive pulmonary disease	0.000676	0.00515	CbGeAlD
Cabazitaxel—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00178	CcSEcCtD
Cabazitaxel—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00178	CcSEcCtD
Cabazitaxel—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000674	0.00177	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00177	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00067	0.00176	CcSEcCtD
Cabazitaxel—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000668	0.00176	CcSEcCtD
Cabazitaxel—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00176	CcSEcCtD
Cabazitaxel—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000662	0.00174	CcSEcCtD
Cabazitaxel—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000662	0.00174	CcSEcCtD
Cabazitaxel—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00174	CcSEcCtD
Cabazitaxel—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00173	CcSEcCtD
Cabazitaxel—Infection—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00173	CcSEcCtD
Cabazitaxel—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00171	CcSEcCtD
Cabazitaxel—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00171	CcSEcCtD
Cabazitaxel—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00171	CcSEcCtD
Cabazitaxel—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00171	CcSEcCtD
Cabazitaxel—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00171	CcSEcCtD
Cabazitaxel—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00171	CcSEcCtD
Cabazitaxel—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000648	0.0017	CcSEcCtD
Cabazitaxel—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000648	0.0017	CcSEcCtD
Cabazitaxel—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000646	0.0017	CcSEcCtD
Cabazitaxel—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000646	0.0017	CcSEcCtD
Cabazitaxel—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00169	CcSEcCtD
Cabazitaxel—Infection—Montelukast—chronic obstructive pulmonary disease	0.000644	0.00169	CcSEcCtD
Cabazitaxel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00169	CcSEcCtD
Cabazitaxel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00169	CcSEcCtD
Cabazitaxel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00064	0.00168	CcSEcCtD
Cabazitaxel—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00168	CcSEcCtD
Cabazitaxel—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00167	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000634	0.00167	CcSEcCtD
Cabazitaxel—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.00167	CcSEcCtD
Cabazitaxel—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000633	0.00167	CcSEcCtD
Cabazitaxel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000629	0.00166	CcSEcCtD
Cabazitaxel—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000625	0.00164	CcSEcCtD
Cabazitaxel—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00163	CcSEcCtD
Cabazitaxel—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000618	0.00163	CcSEcCtD
Cabazitaxel—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.00163	CcSEcCtD
Cabazitaxel—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00161	CcSEcCtD
Cabazitaxel—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00061	0.0016	CcSEcCtD
Cabazitaxel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.0016	CcSEcCtD
Cabazitaxel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000604	0.00159	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00159	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00159	CcSEcCtD
Cabazitaxel—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000595	0.00157	CcSEcCtD
Cabazitaxel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000595	0.00156	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00059	0.00155	CcSEcCtD
Cabazitaxel—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00155	CcSEcCtD
Cabazitaxel—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00155	CcSEcCtD
Cabazitaxel—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00154	CcSEcCtD
Cabazitaxel—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00153	CcSEcCtD
Cabazitaxel—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00153	CcSEcCtD
Cabazitaxel—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000582	0.00153	CcSEcCtD
Cabazitaxel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00151	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000571	0.0015	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.0015	CcSEcCtD
Cabazitaxel—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00057	0.0015	CcSEcCtD
Cabazitaxel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00057	0.0015	CcSEcCtD
Cabazitaxel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.0015	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.0015	CcSEcCtD
Cabazitaxel—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000566	0.00149	CcSEcCtD
Cabazitaxel—Pain—Formoterol—chronic obstructive pulmonary disease	0.000566	0.00149	CcSEcCtD
Cabazitaxel—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000566	0.00149	CcSEcCtD
Cabazitaxel—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000566	0.00149	CcSEcCtD
Cabazitaxel—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000561	0.00148	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00147	CcSEcCtD
Cabazitaxel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00147	CcSEcCtD
Cabazitaxel—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00147	CcSEcCtD
Cabazitaxel—Pain—Montelukast—chronic obstructive pulmonary disease	0.000554	0.00146	CcSEcCtD
Cabazitaxel—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.00145	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.00145	CcSEcCtD
Cabazitaxel—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00145	CcSEcCtD
Cabazitaxel—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.00144	CcSEcCtD
Cabazitaxel—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00143	CcSEcCtD
Cabazitaxel—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00143	CcSEcCtD
Cabazitaxel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000545	0.00143	CcSEcCtD
Cabazitaxel—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00143	CcSEcCtD
Cabazitaxel—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00143	CcSEcCtD
Cabazitaxel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00143	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000541	0.00142	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.00142	CcSEcCtD
Cabazitaxel—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000541	0.00142	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00142	CcSEcCtD
Cabazitaxel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00142	CcSEcCtD
Cabazitaxel—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00141	CcSEcCtD
Cabazitaxel—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00141	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00139	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00139	CcSEcCtD
Cabazitaxel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000523	0.00138	CcSEcCtD
Cabazitaxel—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000523	0.00138	CcSEcCtD
Cabazitaxel—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000523	0.00138	CcSEcCtD
Cabazitaxel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000523	0.00138	CcSEcCtD
Cabazitaxel—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00137	CcSEcCtD
Cabazitaxel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000516	0.00136	CcSEcCtD
Cabazitaxel—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.00135	CcSEcCtD
Cabazitaxel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000514	0.00135	CcSEcCtD
Cabazitaxel—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00135	CcSEcCtD
Cabazitaxel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00135	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00134	CcSEcCtD
Cabazitaxel—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000504	0.00133	CcSEcCtD
Cabazitaxel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.0013	CcSEcCtD
Cabazitaxel—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.0013	CcSEcCtD
Cabazitaxel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00128	CcSEcCtD
Cabazitaxel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00128	CcSEcCtD
Cabazitaxel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00128	CcSEcCtD
Cabazitaxel—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00128	CcSEcCtD
Cabazitaxel—ABCB1—lung—chronic obstructive pulmonary disease	0.000485	0.0037	CbGeAlD
Cabazitaxel—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000482	0.00127	CcSEcCtD
Cabazitaxel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00126	CcSEcCtD
Cabazitaxel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.00125	CcSEcCtD
Cabazitaxel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000475	0.00125	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000467	0.00123	CcSEcCtD
Cabazitaxel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00122	CcSEcCtD
Cabazitaxel—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000461	0.00121	CcSEcCtD
Cabazitaxel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00121	CcSEcCtD
Cabazitaxel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00119	CcSEcCtD
Cabazitaxel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00119	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00119	CcSEcCtD
Cabazitaxel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00118	CcSEcCtD
Cabazitaxel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00117	CcSEcCtD
Cabazitaxel—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000439	0.00115	CcSEcCtD
Cabazitaxel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00115	CcSEcCtD
Cabazitaxel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00115	CcSEcCtD
Cabazitaxel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00113	CcSEcCtD
Cabazitaxel—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00113	CcSEcCtD
Cabazitaxel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00112	CcSEcCtD
Cabazitaxel—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00111	CcSEcCtD
Cabazitaxel—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00111	CcSEcCtD
Cabazitaxel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00109	CcSEcCtD
Cabazitaxel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00109	CcSEcCtD
Cabazitaxel—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00109	CcSEcCtD
Cabazitaxel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00109	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00109	CcSEcCtD
Cabazitaxel—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00108	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00107	CcSEcCtD
Cabazitaxel—Headache—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00107	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00105	CcSEcCtD
Cabazitaxel—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00104	CcSEcCtD
Cabazitaxel—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00104	CcSEcCtD
Cabazitaxel—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.00104	CcSEcCtD
Cabazitaxel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Cabazitaxel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Cabazitaxel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00103	CcSEcCtD
Cabazitaxel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00101	CcSEcCtD
Cabazitaxel—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.000997	CcSEcCtD
Cabazitaxel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.000976	CcSEcCtD
Cabazitaxel—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000369	0.000971	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000947	CcSEcCtD
Cabazitaxel—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.000942	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00092	CcSEcCtD
Cabazitaxel—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000901	CcSEcCtD
Cabazitaxel—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000895	CcSEcCtD
Cabazitaxel—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000875	CcSEcCtD
Cabazitaxel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000871	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000861	CcSEcCtD
Cabazitaxel—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000852	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.000846	CcSEcCtD
Cabazitaxel—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000845	CcSEcCtD
Cabazitaxel—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000839	CcSEcCtD
Cabazitaxel—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000839	CcSEcCtD
Cabazitaxel—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000806	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000779	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.000777	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000776	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000757	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000754	CcSEcCtD
Cabazitaxel—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000725	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000714	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000714	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000712	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00071	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000706	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.000694	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000685	CcSEcCtD
Cabazitaxel—Infection—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00068	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000672	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000668	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000665	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000653	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000624	CcSEcCtD
Cabazitaxel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000623	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000615	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000603	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000595	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00059	CcSEcCtD
Cabazitaxel—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00059	CcSEcCtD
Cabazitaxel—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.00154	CbGpPWpGaD
Cabazitaxel—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000586	CcSEcCtD
Cabazitaxel—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	0.00022	0.00152	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000218	0.0015	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000564	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000214	0.00147	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00056	CcSEcCtD
Cabazitaxel—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00056	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000211	0.00146	CbGpPWpGaD
Cabazitaxel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000541	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000541	CcSEcCtD
Cabazitaxel—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000202	0.00139	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000199	0.00138	CbGpPWpGaD
Cabazitaxel—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00137	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000195	0.00135	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000194	0.00134	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000505	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000491	CcSEcCtD
Cabazitaxel—TUBB6—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000187	0.00129	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000187	0.00129	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000185	0.00128	CbGpPWpGaD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00125	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000181	0.00125	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00018	0.00124	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.00018	0.00124	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00123	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000469	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000178	0.00123	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000175	0.00121	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000175	0.00121	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000174	0.0012	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000173	0.00119	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000173	0.00119	CbGpPWpGaD
Cabazitaxel—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000453	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000172	0.00118	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000171	0.00118	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000171	0.00118	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000168	0.00116	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000168	0.00116	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00116	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000166	0.00115	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000166	0.00115	CbGpPWpGaD
Cabazitaxel—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000435	CcSEcCtD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00114	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000165	0.00114	CbGpPWpGaD
Cabazitaxel—Headache—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000429	CcSEcCtD
Cabazitaxel—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00112	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000162	0.00112	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000161	0.00111	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00016	0.0011	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00016	0.0011	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000157	0.00108	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000157	0.00108	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000156	0.00107	CbGpPWpGaD
Cabazitaxel—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000407	CcSEcCtD
Cabazitaxel—TUBB1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000153	0.00106	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000153	0.00106	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000152	0.00105	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000148	0.00102	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00101	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000146	0.001	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.001	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.000997	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.000988	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	0.000142	0.000978	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.00014	0.000968	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00014	0.000965	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00014	0.000964	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000138	0.000952	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000138	0.00095	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000137	0.000944	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.000943	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000135	0.000933	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000135	0.00093	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000135	0.000929	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000135	0.000929	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000133	0.000921	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000132	0.000909	CbGpPWpGaD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.000907	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000896	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000129	0.000888	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000128	0.000887	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000127	0.000874	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000126	0.000869	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000125	0.000863	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000123	0.000847	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.000841	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000121	0.000836	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.000829	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00012	0.000827	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00012	0.000827	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000119	0.000824	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000116	0.0008	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000116	0.0008	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000116	0.000799	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000113	0.000779	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000112	0.000774	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000112	0.000773	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000111	0.000768	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00011	0.000757	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00011	0.000756	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000108	0.000749	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.000736	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000106	0.000732	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.000728	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000105	0.000727	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.000724	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000718	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.99e-05	0.00069	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.99e-05	0.00069	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.88e-05	0.000682	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9.84e-05	0.000679	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.8e-05	0.000676	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.78e-05	0.000675	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.7e-05	0.00067	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.65e-05	0.000666	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	9.52e-05	0.000657	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	9.52e-05	0.000657	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	9.47e-05	0.000654	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.38e-05	0.000647	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.35e-05	0.000645	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.27e-05	0.00064	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.27e-05	0.00064	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	9.26e-05	0.000639	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.14e-05	0.000631	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.06e-05	0.000625	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	9e-05	0.000621	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	8.98e-05	0.00062	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	8.97e-05	0.000619	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.85e-05	0.000611	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	8.81e-05	0.000608	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	8.71e-05	0.000601	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.51e-05	0.000587	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	8.49e-05	0.000586	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.21e-05	0.000566	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.19e-05	0.000565	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.02e-05	0.000554	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.79e-05	0.000538	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.74e-05	0.000534	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.71e-05	0.000532	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.71e-05	0.000532	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.69e-05	0.00053	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	7.65e-05	0.000528	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.59e-05	0.000524	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.51e-05	0.000518	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.44e-05	0.000514	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	7.39e-05	0.00051	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	7.36e-05	0.000508	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.21e-05	0.000497	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.13e-05	0.000492	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.000487	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.05e-05	0.000486	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.03e-05	0.000485	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.01e-05	0.000484	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	6.98e-05	0.000482	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.88e-05	0.000474	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.78e-05	0.000468	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—chronic obstructive pulmonary disease	6.61e-05	0.000456	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.5e-05	0.000449	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.49e-05	0.000448	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.000444	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.41e-05	0.000442	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.33e-05	0.000437	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.31e-05	0.000436	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.05e-05	0.000418	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.97e-05	0.000412	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.89e-05	0.000407	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.87e-05	0.000405	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.79e-05	0.000399	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.66e-05	0.000391	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.62e-05	0.000388	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.62e-05	0.000388	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.000385	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.57e-05	0.000385	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.47e-05	0.000377	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.36e-05	0.00037	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.29e-05	0.000365	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.2e-05	0.000359	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.14e-05	0.000355	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.08e-05	0.000351	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.00034	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.9e-05	0.000338	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.81e-05	0.000332	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.79e-05	0.000331	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.76e-05	0.000329	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.76e-05	0.000328	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.69e-05	0.000324	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.67e-05	0.000322	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.66e-05	0.000322	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.56e-05	0.000314	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.56e-05	0.000314	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.43e-05	0.000306	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-05	0.0003	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.32e-05	0.000298	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.26e-05	0.000294	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.22e-05	0.000291	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.05e-05	0.00028	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.000276	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.96e-05	0.000273	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.8e-05	0.000262	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.63e-05	0.000251	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.6e-05	0.000249	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.56e-05	0.000246	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.55e-05	0.000245	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.45e-05	0.000238	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.41e-05	0.000235	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.39e-05	0.000234	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.34e-05	0.00023	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.31e-05	0.000229	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.000227	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	3.18e-05	0.000219	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.14e-05	0.000217	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.11e-05	0.000215	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.07e-05	0.000212	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.04e-05	0.00021	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.02e-05	0.000208	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.99e-05	0.000206	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.000206	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.95e-05	0.000204	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.94e-05	0.000203	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.000201	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.87e-05	0.000198	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.75e-05	0.00019	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.73e-05	0.000188	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.69e-05	0.000186	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.6e-05	0.00018	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.57e-05	0.000178	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000171	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.000165	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.000163	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.35e-05	0.000162	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.28e-05	0.000157	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.2e-05	0.000152	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.000149	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.13e-05	0.000147	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.000144	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000143	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.04e-05	0.000141	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.04e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000136	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.000131	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.00013	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.000125	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000124	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.000123	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.000114	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000111	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.59e-05	0.000109	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.000108	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.45e-05	9.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	9.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	9.35e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	9.2e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	8.46e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.17e-05	8.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	7.67e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.1e-05	7.57e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	7.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	7.05e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	7.05e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.68e-06	6.68e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.58e-06	4.54e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.3e-06	4.35e-05	CbGpPWpGaD
